Animal models of depression: challenges from a drug development perspective.
about
Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.Lost but making progress--Where will new analgesic drugs come from?Raphe-Hippocampal Serotonin Neurotransmission In The Sex Related Differences of Adaptation to Stress: Focus on Serotonin-1A Receptor.The tail suspension test.
P2860
Animal models of depression: challenges from a drug development perspective.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Animal models of depression: challenges from a drug development perspective.
@ast
Animal models of depression: challenges from a drug development perspective.
@en
type
label
Animal models of depression: challenges from a drug development perspective.
@ast
Animal models of depression: challenges from a drug development perspective.
@en
prefLabel
Animal models of depression: challenges from a drug development perspective.
@ast
Animal models of depression: challenges from a drug development perspective.
@en
P1476
Animal models of depression: challenges from a drug development perspective.
@en
P2093
Rupniak NM
P304
P356
10.1097/01.FBP.0000087738.21047.91
P577
2003-09-01T00:00:00Z